SCHEMBL30799489

SCHEMBL30799489

CC(C)(NC(=O)[C@@H](N)Cc1c[nH]cn1)C(N)=O

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CTSC P53634 1/20 0.35
▸ GRB2 P62993 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29545820 0.90 CTSC (0.33) CTSC
SCHEMBL13958826 0.88 CTSC (0.34) CTSC
SCHEMBL22369842 0.88 CTSC (0.34) CTSC
SCHEMBL30946342 0.87 CNR2 (0.33) CTSC
SCHEMBL16362464 0.87 CTSC (0.32) CTSC
SCHEMBL31388739 0.82 GRB2 (0.36) GRB2
SCHEMBL31388786 0.82 GRB2 (0.37) GRB2
SCHEMBL30987834 0.81 — —
SCHEMBL3835494 0.80 LTA4H (0.33) —
SCHEMBL3835499 0.80 LTA4H (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240116985-A1 STAPLED PEPTIDES AND METHODS THEREOF PARABILIS MEDICINES, INC. 2024-04-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240116985-A1 STAPLED PEPTIDES AND METHODS THEREOF CTNNB1, APC, CTNNA1 CTSC 732/4885GRB2 600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback